Clinical Trials Directory

Trials / Unknown

UnknownNCT04983563

Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units

Assessment of Actigraphy in the Management of Neonatal Opioid Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of this study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome of hospitalized newborn in intensive care units

Detailed description

Hospitalized newborn in intensive care units can receive opioids to manage pain or sedation. Neonatal opioid abstinence syndrome can occur when newborn receive opioid treatment for a long time. Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal abstinence syndrome but they are subjective. The majority of items in these scores are motor skills items. Actigraphy allows to measure objectively the newborn motricity. This study will analyse the correlation between actigraphy and Lipsitz scoring system.

Conditions

Interventions

TypeNameDescription
DEVICEActigraphy, eTactActigraphy will be realized twice a day during 30 minutes and Lipsitz scoring system will be realized at the same moment to analyze the correlation between Lipsitz scoring system and actigraphy.

Timeline

Start date
2021-03-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-07-30
Last updated
2021-07-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04983563. Inclusion in this directory is not an endorsement.